Medistep Healthcare Ipo
Objects of the Issue
Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
Working Capital requirements
General Corporate Purpose
Medistep Healthcare IPO Review
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Fast Track Finsec Pvt Ltd
Application | Lot Size | Shares | Amount |
Retail Minimum | 2 | 6,000 | ₹2,58,000 |
Retail Maximum | 2 | 6,000 | ₹2,58,000 |
S-HNI Minimum | 3 | 9,000 | ₹3,87,000 |
IPO Open Date: | August 8, 2025 |
IPO Close Date: | August 12, 2025 |
Basis of Allotment: | August 13, 2025 |
Refunds: | August 14, 2025 |
Credit to Demat Account: | August 14, 2025 |
IPO Listing Date: | August 18, 2025 |
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹7.62 | ₹7.27 | ₹0.19 | ₹7.10 |
2023 | ₹27.74 | ₹26.31 | ₹0.92 | ₹14.66 |
2024 | ₹31.63 | ₹27.66 | ₹2.91 | ₹14.96 |
June 2024 | ₹11.25 | ₹9.86 | ₹1.02 | ₹24.02 |
KPI | Values |
ROE: | 52.14% |
ROCE: | 69.15% |
EBITDA Margin: | 11.62% |
PAT Margin: | 8.52% |
Debt to equity ratio: | 0.03 |
Earning Per Share (EPS): | ₹19.96 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 28.46% |
Net Asset Value (NAV): | ₹80.11 |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Fabino Enterprises Limited | 0.23 | 135 | 1.15% | 19.80 | 0.05 Cr. |
Achyut Healthcare Limited | 0.34 | 10.08 | 2.53% | 18.28 | 0.57 Cr. |
IPO Open Date: | August 8, 2025 |
IPO Close Date: | August 12, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹43 Per Share |
Issue Size: | Approx ₹16.10 Crores |
Fresh Issue: | Approx ₹16.10 Crores |
Lot Size: | 3,000 Shares |
Issue Type: | Fixed Price Issue |
IPO Listing: | NSE SME |
Retail Quota: | Not more than 50% |
NII Quota: | Not more than 50% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |